283 related articles for article (PubMed ID: 17470784)
21. MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.
Labisso WL; Wirth M; Stojanovic N; Stauber RH; Schnieke A; Schmid RM; Krämer OH; Saur D; Schneider G
Cell Cycle; 2012 Apr; 11(8):1593-602. PubMed ID: 22456335
[TBL] [Abstract][Full Text] [Related]
22. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses.
Bolden JE; Shi W; Jankowski K; Kan CY; Cluse L; Martin BP; MacKenzie KL; Smyth GK; Johnstone RW
Cell Death Dis; 2013 Feb; 4(2):e519. PubMed ID: 23449455
[TBL] [Abstract][Full Text] [Related]
23. BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma.
Shao Y; Aplin AE
Cell Death Differ; 2012 Dec; 19(12):2029-39. PubMed ID: 22858545
[TBL] [Abstract][Full Text] [Related]
24. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.
Deng J; Carlson N; Takeyama K; Dal Cin P; Shipp M; Letai A
Cancer Cell; 2007 Aug; 12(2):171-85. PubMed ID: 17692808
[TBL] [Abstract][Full Text] [Related]
25. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.
Peart MJ; Smyth GK; van Laar RK; Bowtell DD; Richon VM; Marks PA; Holloway AJ; Johnstone RW
Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3697-702. PubMed ID: 15738394
[TBL] [Abstract][Full Text] [Related]
26. Synergistic induction of apoptosis by p53-inducible Bcl-2 family proteins Noxa and Puma.
Nakajima W; Tanaka N
J Nippon Med Sch; 2007 Apr; 74(2):148-57. PubMed ID: 17507791
[TBL] [Abstract][Full Text] [Related]
27. EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.
Nakagawa T; Takeuchi S; Yamada T; Ebi H; Sano T; Nanjo S; Ishikawa D; Sato M; Hasegawa Y; Sekido Y; Yano S
Cancer Res; 2013 Apr; 73(8):2428-34. PubMed ID: 23382048
[TBL] [Abstract][Full Text] [Related]
28. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
29. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
Lillehammer T; Engesaeter BO; Prasmickaite L; Maelandsmo GM; Fodstad O; Engebraaten O
J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
[TBL] [Abstract][Full Text] [Related]
30. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
31. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.
Mühlethaler-Mottet A; Meier R; Flahaut M; Bourloud KB; Nardou K; Joseph JM; Gross N
Mol Cancer; 2008 Jun; 7():55. PubMed ID: 18549473
[TBL] [Abstract][Full Text] [Related]
32. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.
Zhang XD; Gillespie SK; Borrow JM; Hersey P
Mol Cancer Ther; 2004 Apr; 3(4):425-35. PubMed ID: 15078986
[TBL] [Abstract][Full Text] [Related]
33. Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways.
Zhang L; Lopez H; George NM; Liu X; Pang X; Luo X
Cell Death Differ; 2011 May; 18(5):864-73. PubMed ID: 21113147
[TBL] [Abstract][Full Text] [Related]
34. Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation.
Alfredsson J; Puthalakath H; Martin H; Strasser A; Nilsson G
Cell Death Differ; 2005 Feb; 12(2):136-44. PubMed ID: 15592435
[TBL] [Abstract][Full Text] [Related]
35. BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.
Locatelli SL; Cleris L; Stirparo GG; Tartari S; Saba E; Pierdominici M; Malorni W; Carbone A; Anichini A; Carlo-Stella C
Leukemia; 2014 Sep; 28(9):1861-71. PubMed ID: 24561519
[TBL] [Abstract][Full Text] [Related]
36. Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl-2/Bcl-x(L) versus induction of the BH3-only protein Bim.
Zimmermann AK; Loucks FA; Le SS; Butts BD; Florez-McClure ML; Bouchard RJ; Heidenreich KA; Linseman DA
J Neurochem; 2005 Jul; 94(1):22-36. PubMed ID: 15953346
[TBL] [Abstract][Full Text] [Related]
37. BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.
Del Gaizo Moore V; Schlis KD; Sallan SE; Armstrong SA; Letai A
Blood; 2008 Feb; 111(4):2300-9. PubMed ID: 18056841
[TBL] [Abstract][Full Text] [Related]
38. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
[TBL] [Abstract][Full Text] [Related]
39. An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.
West AC; Mattarollo SR; Shortt J; Cluse LA; Christiansen AJ; Smyth MJ; Johnstone RW
Cancer Res; 2013 Dec; 73(24):7265-76. PubMed ID: 24158093
[TBL] [Abstract][Full Text] [Related]
40. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.
Hogg SJ; Newbold A; Vervoort SJ; Cluse LA; Martin BP; Gregory GP; Lefebure M; Vidacs E; Tothill RW; Bradner JE; Shortt J; Johnstone RW
Mol Cancer Ther; 2016 Sep; 15(9):2030-41. PubMed ID: 27406984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
